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Objectives: MRSA is a major antimicrobial resistance (AMR) pathogen. The reservoir of infecting isolates is colon-
ization, which is the site of evolutionary selection. The aimwas to identify if AMRs in colonizing MRSA populations
diversified and potential mechanisms of resistance gene transfer in vivo.
Methods: Nasal swabs from 38 MRSA carriers admitted to hospital were plated and 20 individual colonies from
each patient tested for phenotypic antibiotic susceptibility and genetically for lineage, carriage of four prophages
and three plasmid families. Free bacteriophages were detected in swabs as well as their capacity for transducing
resistance genes.
Results: Nine (24%) patients carried phenotypic AMR variants and 24 (63%) carried prophage and plasmid var-
iants. If a single colony was selected for testing, the probability of detecting all AMR in that patient was 87%.
Sixty-four different AMR and mobile genetic element (MGE) profiles were detected, mostly in the MRSA CC22
background (where CC stands for clonal complex), with up to 8 profiles per patient. Nearly half of the patients
carried detectable free bacteriophages and phages successfully transduced resistance genes between laboratory
and patient isolates in vitro. WGS showed MRSA core genomes were stable, while AMR and MGEs varied.
Conclusions: ‘Clouds’ of MRSA variants that have acquired or lost AMR and MGEs are common in nasal colonizing
populations and bacteriophages may play an important role in gene transfer. Accurate estimation of AMR and
genetic variability has implications for diagnostics, epidemiology, antimicrobial stewardship and understanding
the evolutionary selection of AMR in colonizing populations.
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Introduction
Antimicrobial resistance (AMR) risks the future of modern medi-
cine and one of the most problematic pathogens globally is
MRSA.1,2 Resistance to all classes of antimicrobials has been
detected in MRSA and the majority are due to resistance genes
encoded on mobile genetic elements (MGEs) such as plasmids
and transposons.3,4 Despite the prevalence of these resistances,
they do not appear to be accumulating into fully drug-resistant
clones. Instead, epidemiological evidence suggests resistances
may transfer frequently and may also be lost frequently.5,6
However, little is known about AMR transfer in the host and the
factors that control transfer, selection or deselection of resis-
tances in MRSA. To reduce AMR pathogens globally, we must
understand the evolutionary pressures acting on colonizing
pathogens and develop strategies to reduce AMR selection.
The reservoir of infecting isolates is colonization in the nose.7–9
In a recent study of Staphylococcus aureus colonization in gnoto-
biotic piglets, extremely high levels of horizontal gene transfer
(HGT) and loss of MGEs were detected.10 In particular, bacterio-
phages and plasmids transferred, including resistance plasmids,
despite no exposure to antimicrobials. Loss of transferred ele-
ments was also common and individual piglets carried unique
populations despite close contact. Mixed populations with a var-
iety of MGE profiles were maintained during the course of the
16 day experiment, rather than selection of the fittest variant.
HGT and loss during piglet co-colonization was significantly
more common than during in vitro culture.10
Whether this variation occurs during human colonization is
unclear. Although most humans are colonized with a single
clone,11–13 recent studies have suggested ‘clouds’ of clonal var-
iants can be detected. Specifically, Harris et al.14 showed that a
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colonized staff member in a neonatal intensive care unit that was
the suspected reservoir of an outbreak carried variants with four to
five SNPs and variation in an erythromycin resistance plasmid. Tong
et al.15 showed that a colonized patient in a resource-poor hospital
setting that was the likely reservoir of hospital outbreaks carried
variants with 147 SNPs over 9 weeks. Golubchik et al.16 showed
that for 13 colonized patients where primary plate colonies were
pooled and frozen, 8–12 subcultured colonies showed variation
in SNPs and MGEs. Similarly, in chronically infected cystic fibrosis
patients, Goerke et al.17 showed that bacteriophages moved into
and out of S. aureus populations over time. Chronic cystic fibrosis
infection with Pseudomonas aeruginosa is also known to lead to
diversification in bacteriophage and AMR profiles.18–20
The aim of this study was to investigate phenotypic AMR vari-
ation in MRSA colonizing populations of humans, as well as asses-
sing genotypic variation in MGEs and potential mechanisms of
gene transfer. Thirty-eight patients admitted to St George’s NHS
Healthcare Trust who were colonized with MRSA were included
and 20 individual colonies from their primary nasal swab plates
were assessed. We found evidence of frequent AMR gene
transfer and even higher levels of MGE transfer. Generalized trans-
ducing phages capable of transferring AMR genes were prevalent
in swab material.
Materials and methods
Sample selection and bacterial culture
Anterior nasal swabs from patients admitted to St George’s Hospital
(London, UK) were routinely plated ontomannitol salt agar plates contain-
ing 2 mg/L oxacillin (Sigma–Aldrich) and incubated for 48 h at 378C to
identify MRSA. Twenty-twoMRSA-positive plates and their swabswere col-
lected between February and April 2012 from carriers positive for nares
culture and negative for groin culture; 16 swabs were collected from
January to March 2013 from patients positive for nares culture (coloniza-
tion of groin unknown). From each positive plate, 20 well-separated col-
onies (which will be referred to as subisolates) were selected at random
and replated separately onto brain heart infusion agar (BHIA; Sigma–
Aldrich) and incubated for 24 h at 378C. Each subisolate obtained from
BHIA plates was suspended in 1 mL of sterilized brain heart infusion
broth (BHIB; Sigma–Aldrich) supplemented with 20% glycerol (Sigma–
Aldrich), frozen and stored at 2808C until further analysis.
Antibiotic susceptibility testing and AMR profiles
For each subisolate, susceptibility to 13 antibiotics was determined by the
disc diffusion test in accordance with BSAC guideline version 11.21 An AMR
profile is the combination of all resistances carried in a single isolate.
Mathematical analysis
To estimate the probability of detecting all resistances in a discrete
number of colonies, we used the distribution of AMR profiles from our 38
patients and 20 subisolates to run a simulation (Table S1, available as
Supplementary data at JAC Online). This simulation assumed the same
population of patients, with the same AMR profile distribution, and then
randomly sampled one colony from each patient and recorded whether
all resistances were seen. This was repeated 10000 times in order to gen-
erate a probability of seeing all resistances (equal to the number of simu-
lations where all AMR profiles were seen out of the 10000). The same
simulation was performed with two colonies picked from each patient,
three colonies etc. up to a maximum of 100. We also analytically
calculated the probability of seeing all resistances assuming that all
patients had only one or two AMR profiles (using data from a subset of
37/38 of our patients).
DNA extraction and amplification
Total genomic DNA from each single subisolate was extracted using the
bacterial genomic DNA purification kit PurElute (Edge Biosystems) and
2.5 mL of lysostaphin (Sigma–Aldrich) was added. The restriction modifi-
cation (RM) test was used to identify MRSA lineages as CC22, CC8, CC1
or CC45 (where CC stands for clonal complex).22 PCR was used to detect
four major phage families based on their integrase gene (F1, F2, F3
and F6),23 two types of plasmid based on the replication locus (rep10 and
rep20)
3 and the putative antiseptic resistance gene (qacA) typically found
on large plasmids, as these have previously been detected in MRSA CC22
populations.3 PCR was also used to screen for the presence of tra genes,
necessary for conjugative transfer.3 All primers are listed in Table S2.
WGS
Five subisolates from Patient 19were selected forWGS. Patient 19 had two
AMR and three MGE profiles (Table 1), and one subisolate with each profile
(three subisolates) and two additional random subisolates from Patient 19
were chosen. Two sequenced subisolates (19A and 19B) were used in a
transduction experiment as a recipient and donor (see below) and two
random progeny cells were also sequenced.
WGS was performed using the Ion TorrentTM Personal Genome Machine
(Ion PGMTM) in conjunction with Ion TorrentTM workflow reagents (Life
Technologies, Paisley, UK). Genomic DNA (100 ng) was fragmented by
sonication using a BioRuptor UD-200 (Diagenode, Belgium) and a library
prepared using the Ion Plus Fragment Library Kit according to themanufac-
turer’s instructions. The fragmented DNA was end-repaired, ligated to
Ion-compatible adapters and nick-translated. To produce a median frag-
ment size of 330 bp, each library was size-selected using a 2% E-Gel
SizeSelect Agarose Gel (Life Technologies) and subjected to qPCR (Ion
Library Quantitation Kit) for quantification. Five barcoded libraries were
pooled in equimolar amounts and clonally amplified on Ion Sphere
ParticlesTM (ISP) using the Ion OneTouch instrument. The template-positive
ISPs were enriched using the Ion OneTouch ES and sequenced on the Ion
316 chip using a 200 bp sequencing kit. Sequence quality was assessed
using Fastqc (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/).
Sequence assemblywas performed usingMIRAv3.9.1724with default para-
meters for Ion Torrent data. Manual analysis and sequence inspection were
performed using the Artemis25 and ACT26 genome visualization tools. SNP
identification and phylogenetic reconstructions were performed as previ-
ously described, except that the reference genome was CC22 isolate HO
5096 0412 (accession number HE681097).27 Circos28 was used as a gen-
ome visualization tool to enable the identification andanalysis of similarities
and differences arising from genome comparisons. Contigs containing dif-
ferences between genomes were analysed by BLAST29,30 to further ascer-
tain gene content. If the contigs were similar to plasmid sequences in
GenBank, then these contigs were searched by BLAST in an attempt to
find reads that can circularize the plasmid.
Phage isolation and titration
The bacteriophage isolation assay wasmodified from Aswani et al.31 Each
original nasal swab stored in transport medium (Nuova Aptaca) was
placed into a 15 mL Falcon tube containing 2–3 mL of phage buffer
(50 mM Tris-HCl pH 7.8, 100 mM NaCl, 1 mM MgSO4, 4 mM CaCl2 and
1 g/L gelatin; Sigma–Aldrich). Suspended swabs were vortexed for 1 min
and incubated for 2 h at 378C at a shaking speed of 200 rpm. After incu-
bation, the supernatant was filtered through a 0.22 mm filter (Sigma–
Aldrich) to remove the bacterial cells and stored at 48C.
Stanczak-Mrozek et al.
2192
Isolated phages were grown on RN4220 strain, centrifuged for 10 min
at 4000 rpm and filtered through a 0.22 mm filter. The presence of phages
was confirmed by the observation of clear phage plaques using the
double-layer agar (DLA) technique. Briefly, 200 mL of phage mixture was
mixed with 200 mL of recipient cells (RN4220 or 19B) in log phase
(OD¼1 at A600) followed by addition of 30 mL of 1 M CaCl2. Samples
were left to rest at room temperature for 15 min, mixed with 7 mL of
top agar molten to 508C and poured over set phage bottom agar plates.
Phage agar was prepared by mixing 3 g/L yeast extract (Sigma–Aldrich),
3 g/L casamino acids (Fisher Scientific), 5.9 g/L NaCl (Sigma–Aldrich) and
either 10 g/L agar (Sigma–Aldrich) (bottom) or 3.3 g/L agar (top). Plates
were incubated at 308C for 24 h and the number of plaques counted to
calculate the pfu/mL of lysates.
From the DLA plates, two well-separated plaques were chosen for fur-
ther analysis, one from Patient 19 (called F19) and one from Patient 20
(F20). Plaques were excised, resuspended in 2 mL of phage buffer and
Table 1. AMR resistance, genetic variability and free phages detected in 38 MRSA carriers
Patient CC
Total
unique
profiles
Phenotypic AMR resistance Genotypic prophage, plasmid and qacA PCR
PhagesCIP ERY CLI GEN SXT TMP MUP TET RIF FUS phi1 phi2 phi3 phi6 rep10 rep20 qacA
37 22 8 8i 8 8 13 8 2
34 22 4 17 12 2
36 22 4 1 3 1 +
25 22 3 3 1 2
19 22 3 19 19 19 4 +
20 22 3 19 19 19 3 +
29 22 3 18 9 2
38 22 2 17 17 2
12 22 2 4 2
10 22 2 2 2
18 22 2 12 8 ND
24 22 2 19 2
30 22 2 16 +
27 22 2 2 2
28 22 2 15 +
31 22 2 1 8 +
16 22 2 15 +
6 22 2 4 2
32 22 2 3 +
17 22 2 19 +
11 22 2 5 2
26 22 2 16 2
3 22 1 +
2 22 1 +
15 22 1 +
1 22 1 +
23 22 1 +
14 22 1 +
4 22 1 +
5 22 1 2
9 22 1 2
8 22 1 2
13 22 1 2
7 22 1 2
22 1/22 2 1 19 1 2
33 45 2 15 2
35 45 3 1 1 2
21 8 1 2
CIP, ciprofloxacin; ERY, erythromycin; CLI, clindamycin; GEN, gentamicin; SXT, sulfamethoxazole/trimethoprim; TMP, trimethoprim; MUP, mupirocin; TET,
tetracycline; RIF, rifampicin; FUS, fusidic acid; i, inducible resistance to clindamycin; +, free phages detected in the nasal swab; ND, not done.
Total unique profiles is the number of unique combinations of AMR and MGE profiles observed in each patient. Filled cells indicate AMR resistance or gene
presence in 20 subisolates, unfilled cells are AMR susceptibility or gene absence in 20 subisolates and numbers indicate the number of resistant or posi-
tive subisolates out of 20.
All 760 subisolates were resistant to penicillin and oxacillin and susceptible to chloramphenicol.
Within-host MRSA diversity
2193
JAC
filtered through a 0.22 mm filter. Next, 100 mL of phage solution was
added to mid-log-phase RN4220 resuspended in 7 mL of phage buffer,
mixed with 7 mL of BHIB and incubated at 30–328C at 70 rpm overnight.
Lysates were centrifuged for 10 min at 4000 rpm, filtered through a
0.22 mm filter and stored at 48C.
Generalized transduction
RN4220 was used as a phage-negative recipient strain and strain KSermB
was constructed as a phage-negative donor strain in the RN4220 back-
ground (Table S3). RN4220 was chosen as it is RM deficient and able
to accept DNA from the CC22 lineage used in this study. Two isolates
from Patient 19, either erythromycin resistant (19A) or susceptible
(19B), were also chosen as a donor and a recipient, respectively. Strain
KSermB was constructed by electroporation of S. aureus RN4220 by
plasmid pCN50::ermB, constructed by cloning the entire erm(B) gene
from S. aureus N315 into pCN50 and transforming into Escherichia
coli DH5a. Briefly, purified plasmid was electroporated32 into RN4220 in
the presence of 0.5 M sucrose (Sigma–Aldrich) and a subinhibitory con-
centration of erythromycin (0.15 mg/L; Sigma–Aldrich), as recom-
mended by Bru¨ckner,33 incubated at 378C for 2–3 h and then plated
out onto BHIA supplemented with 0.5 M sucrose and 30 mg/L erythro-
mycin and incubated for 24–48 h. The presence of erm(B) was confirmed
by PCR.
To prepare lysates for transduction, donor strains (KSermB or 19A)
resistant to erythromycin were grown at 378C with shaking at 80 rpm
until log phase (OD¼0.5–1 at A600). Bacteria were spun down and resus-
pended in 7 mLof phage buffer plus 7 mLof BHIB. FilteredF80a phages or
phages isolated from swabs (F19 andF20) were added,mixed gently and
incubated at room temperature for 10 min. Tubes were placed into a
waterbath and incubated at 30–328C with shaking at 80 rpm. They were
checked every 2 h and mixed gently. If after 6 h of incubation the visible
effect of clearance was not observed, then samples were left overnight.
After overnight incubation, samples were centrifuged for 10 min at
4000 rpm and filtered through a 0.22 mm filter.
The transduction assay wasmodified from Varga et al.34 and all strains
used were negative for the presence of tra genes by PCR. Recipient bac-
teria (RN4220 or 19B) were grown in BHIB overnight at 378C with shaking.
After incubation, the bacterial culture was centrifuged for 10 min at
4000 rpm and resuspended in 1 mL of LK broth (1% tryptone, 0.5%
yeast extract and 0.7% KCl; Sigma–Aldrich). Recipient cells were mixed
with 1 mL of LK broth, phage lysate and CaCl2 (added to a final concentra-
tion of 8 mM). Samples were incubated at 318C for 45 min. Control tubes
with recipient cells only and phage lysate only were also prepared. After
incubation, ice-cold 0.02 M sodium citrate was added (Honeywell
International) to a final concentration of 15 mM and samples centrifuged
at 4000 rpm for 10 min. The supernatant was decanted and the pellet
resuspended in 1 mL of ice-cold 0.02 M sodium citrate and left on ice
for ≥2 h. Samples were spread onto LK plates prepared by mixing LK
broth components with 5 g of bacteriological agar supplemented with
0.05% sodium citrate and 0.15 mg/mL erythromycin, incubated at 378C
for 60 min and then overlaid with 4–5 mL of LK top agar supplemented
with 30 mg/L erythromycin. Plates were incubated for 48 h at 378C. The
number of transductant cells was counted and expressed as the number
of transductant cells/mL, instead of the commonly used frequency of
transduction (pfu/cfu), as not all particles will carry virulent phage gen-
ome and cause lysis. The same experiments were performed using lysates
madewithout addition of exogenous bacteriophages (donor cells only). To
confirm that transductant cells did not result from transformation, each
experiment was repeated in the presence of 20 mg/mL DNase (Promega).
All transductant colonies were picked and passaged onmannitol salt agar
and BHIA supplemented with 30 mg/L erythromycin. DNA from transduc-
tant cells was extracted and the presence of erm(C) or erm(B) confirmed
by PCR.
Statistical analysis
Fisher’s exact test was used to compare the presence of phages or
detected variation in patient populations from swabs collected in 2012
versus those in 2013. Differences in phage titres or transduction frequency
were analysed by the unpaired Student’s t-test and differences were
considered statistically significant at P,0.05.
Results
AMR differences within each patient
The majority of patients (89.5%) were colonized by subisolates
belonging to the common UK healthcare-associated (HA)-MRSA lin-
eage CC22 (Table 1).5,35Twopatients (5.3%)were colonized byMRSA
CC45 lineage and one patient by MRSA CC8 (2.6%). Only one patient
(2.6%) was found to be colonized by subisolates belonging to two
different lineages (CC1 and CC22).
Nine (23.7%) of the 38 patients were colonized with phenotyp-
ically distinct MRSA subisolates (Figure 1 and Table 1). Of these,
five patients (Patients 19, 20, 22, 31 and 36) carried only one sub-
isolate of 20 with a divergent AMR profile, one patient (Patient 35)
carried two subisolates of 20 that differed from each other as well
as differing from the remaining eighteen subisolates (these iso-
lates were CC45, and are red in Figure 1), two patients (Patients
34 and 38) carried three subisolates with a divergent AMR profile,
and one patient (Patient 37) carried eight subisolates with the
same divergent AMR profile. Figure 1 also indicates the prevalence
of AMR profiles carrying the most resistances (filled). In four
patients with AMR variation, the most prevalent AMR profile also
carried the highest number of resistances, but in four cases the
most prevalent AMR profile did not carry the most resistances,
and in one case the two AMR profiles had the same number of
resistances (CC1; Figure 1 in grey). There was no significant differ-
ence in the proportion of patients showing phenotypic variation
Figure 1. Phenotypic AMR profiles in 38 MRSA carriers. Each circle
represents an AMR profile and connected circles are different AMR
profiles from the same carrier. Circle size is proportional to AMR profile
incidence in each patient and filled circles represent the AMR profile with
the most resistances in that carrier. Black is lineage CC22, blue is lineage
CC8, red is lineage CC45 and grey is lineage CC1. This figure appears in
colour in the online version of JAC and in black and white in the print
version of JAC.
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between samples collected in 2012 (Patients 1 to 22) and those
collected in 2013 by Fisher’s exact test.
An extensive range of variant AMR profiles were detected
within the CC22 MRSA clonal population, suggesting the acquisi-
tion and loss of AMR genes is frequent, consistent with previous
studies.5,9 Overall, all subisolates were resistant to penicillin and
oxacillin, which is expected as the primary plates contained oxa-
cillin, 89% were resistant to ciprofloxacin, 26% were resistant to
gentamicin, 46.7% were resistant to erythromycin, 40.3% were
resistant to clindamycin, 8.5% were resistant to co-trimoxazole,
13.2% were resistant to trimethoprim, 6.4% were resistant to
mupirocin, 0.13% were resistant to tetracycline, 0.26% were
resistant to rifampicin and 5.13% were resistant to fusidic acid.
Resistance to chloramphenicol was not detected.
Choosing colonies for AMR analysis
From our simulations, sampling 18 colonies is likely to give a 95%
probability of detecting all resistances present in the sample
(Figure 2). This would rise to 99%only if 50 colonies were sampled.
If only one or two AMR profiles were found in all patients (as was
the case for 37/38 of our patients), the analytical analysis showed
that sampling eight colonies would give a 95% probability of
detecting all resistances (Figure 2).
Genetic variation within each patient
The phenotypic differences between subisolates could be a reflec-
tion of the genetic variation caused by the acquisition or loss of
MGEs such as plasmids, mediated by transducing phages. To fur-
ther examine the samples, the genetic differences between the
subisolates were analysed by PCR for four integrated prophage
families, two plasmid (rep10 and rep20) families and qacA.
Overall, 24 (63.2%) patients were colonized by genotypically
different subisolates (Figure 3 and Table 1). The number of subiso-
lates with genetic and AMR variation identified per patient ranged
from one to eight (Table 1). In total, 64 different profiles were
detected. The majority of patients had between one and four
subisolates differing from the rest. Phenotypic variation in AMR
correlated well with genetic differences.
Further analysis of phenotypic and genotypic subisolates
showed each individual subisolate differed by only one or two
AMR or MGE differences from other subisolates from the same
patient. This included Patient 37 (Table 1), where eight variant
profiles were identified; however, each variant differed from at
least one other variant by only one AMR or MGE. These data are
consistent with all variants in each patient originating from a
single progenitor that has acquired or lost genes, rather than
co-colonization with multiple MRSA CC22 introductions. The
exception was Patient 22 (Table 1), who carried isolates from
two MRSA lineages.
The most variation within nasal carriage populations was asso-
ciated with the presence/absence of the rep20 gene in 50% of
patients and variation in the presence of the qacA gene in 37.5%
of patients. There was a strong positive correlation (Fisher’s exact
test, P,0.0001) between susceptibility to erythromycin and lack
of the rep10 gene. All subisolates susceptible to erythromycin
were negative for the rep10 gene by PCR. Erythromycin resistance
encoded by the erm(C) gene is often carried on a small non-
conjugative plasmid with a rep10 replication locus.
3
All subisolates had at least one prophage in the genome: 73%
(552 out of 760) of subisolates were positive forF1, 84% (640) for
F2, 82% (620) for F3 and 10% (78) for F6. F2 or F3 bacterio-
phage integrase gene was stable in all tested patients, while the
other phages and plasmids showed evidence of instability.
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Figure 2. Probability of seeing all resistances in the patient by number of
colonies sampled. The analytic solution has a higher probability as it
assumes each patient only has up to two AMR profiles, whilst the
simulation output (from 10000 simulations) includes a patient with
three profiles.
Figure 3. Genotypic diversity in 38 MRSA carriers. Each circle represents
an MGE profile based on the presence or absence of four phages, two
plasmids and the qacA gene. Connected circles are different MGE profiles
from the same carrier. Circle size is proportional to MGE profile incidence in
each patient and filled circles represent the MGE profile with the most
phage and plasmid genes in that carrier. Black is lineage CC22, blue is
lineage CC8, red is lineage CC45 and grey is lineage CC1. This figure
appears in colour in the online version of JAC and in black and white in
the print version of JAC.
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Comparison of swabs collected in 2012 showed less MGE diversity
than those collected in 2013 (Fisher’s exact test, P,0.05).
The WGS analysis of five subisolates from Patient 19 (repre-
senting two AMR profiles and three MGE profiles) revealed
extremely stable core genomes and no microvariations in the
form of SNPs were detected. Differences between the subisolates
in plasmids were consistent with AMR profile and PCR analysis.
Specifically, two subisolates carried a 28 kb plasmid containing
the qacA gene and showing an almost complete BLAST match
to sequences deposited in the GenBank database as plasmid
pSK1 (GU565967.1). Four subisolates carried a small 2.4 kb plas-
mid with erm(C) gene that matched 100% with plasmid CN1
(CP003981.1) (Figure S1).
Bacteriophages from the swabs
Overall, 16 of 38 (42%) original nasal swabs were positive for the
presence of lytic bacteriophages against S. aureus RN4220. The
presence of bacteriophages did not correlate with phenotypic
and genetic variation (Fisher’s exact test, P¼1).
Evidence of transducing ability of bacteriophages
from the swabs
F19 and F20 and the control laboratory phage 80a were grown
on erythromycin-resistant strain KSermB in liquid culture and all
produced phage titres of.104 pfu/mL (Figure S2). Phage 80a pro-
duced a significantly higher value of phage titre (108) compared
with the phage titres of F19 and F20 (t-test, P,0.01). When
grown on 19A, the phage titres were lower (.106) and, again,
phage titres of F19 and F20 were significantly lower (.102)
(t-test, P,0.05) (Figure S2). Control experiments without the add-
ition of exogenous bacteriophages on KSermB (prophage free) or
19A (carrying F1, F2 and F3 family prophages) resulted in a
mean of 0 or 6 pfu/mL, respectively, which is significantly lower
than when exogenous phages were added (P,0.001). This indi-
cates low levels of induction of the endogenous prophages
found in the 19A genome under non-stressful conditions.
All of the tested phages (F19, F20 and 80a) were capable of
generalized transduction of erythromycin resistance genes
(Figure 4). Free bacteriophages F19 and F20 were equally cap-
able of transducing erythromycin resistance genes from KSermB
into RN4220 strains compared with 80a phage, despite the
lower lytic phage titre. High numbers of transductant cells were
observed when phages 80a or F19 were multiplied on the 19A
donor strain and used to transfer the erm(C) gene into RN4220.
Free phage F20 was less efficient (P,0.01) compared with
phage 80a. Colonizing subisolate 19A was capable of acting as
a donor and 19B was capable of acting as a recipient cell. All
phages grown on 19A were capable of transferring the erm(C)
gene into the 19B recipient strain; however, F19 and F20 were
not as efficient as phage 80a (P,0.001).
No statistically significant difference was found between the
experiments with and without the addition of DNase (data not
shown), indicating that transformation was not responsible for
HGT. Both parents were negative by PCR for tra genes, which are
necessary for conjugation. Therefore, HGT was likely due to
bacteriophage-mediated transduction.
To confirm plasmid transfer, two progeny cells were compared
by WGS analysis with the donor 19A and recipient 19B isolates.
The donor strain and both progeny carried the 2.4 kb plasmid
with the erythromycin resistance gene erm(C), which matched
the CN1 plasmid (CP003981.1). Apart from the presence of the
CN1 plasmid, both progeny had the same WGS as both the
donor and the recipient strains. WGS data have been deposited
in the European Nucleotide Archive under accession number
PRJEB7630.
Discussion
MRSA populations in the nose of human carriers varied in AMR pro-
files in 24% of colonized patients and the presence of MGEs in
63.2% of patients. Profiles varied despite most patients being
colonized with a single MRSA clonal type. This suggests frequent
HGT and loss of resistance genes and MGEs between isolates,
both between patients5,9,36 and within patient populations.
Recent studies also demonstrated an extremely high level of plas-
mid and phage transfer between isolates in an experimental pig-
let colonization model,10 even without antimicrobial selection.
HGTof MGEs between S. aureus is thought to be a major contribu-
tor to the evolution, maintenance and success of new epidemic
strains adapted to antimicrobials, new hosts and stresses.37
Generalized transduction is themost likelymechanism of high-
level HGT in the nose.4 Free phages were detected in the nasal
swabs of nearly half of the patients, which is substantially higher
than previous reports.31,38 This may be due to the choice of
S. aureus RN4220 as the host strain, as it is negative for known
RM systems and therefore susceptible to lytic phage DNA that is
normally restricted.4 It is possible a higher rate of lytic bacterio-
phages in the nose may be detectable with a broader range
or more closely related host strains.4,39 Importantly, we have
demonstrated that the free phages found in nasal swabs can be
generalized transducing phages and therefore responsible for HGT.
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Figure 4. Transduction of resistance genes using phages isolated from nasal
swabs. Phages 80a (control), F19 and F20 transduced erythromycin
resistance genes from donors KSermB or 19A [erm(C)] to recipients RN4220
or 19B. If no exogenous phages were added, no transduction was detected.
F20 transduced resistance at a lower frequency than both 80a and F19
when strains were grown on 19A and resistance transferred to RN4220
(t-test, P,0.001 and P,0.01, respectively). 80a transduced resistance at a
higher frequency than F19 and F20 when strains were grown on 19A
and resistance transferred to 19B (t-test, P,0.001). Transductant cells/mL
of phage lysate are expressed as means of at least three different
experiments with three replicates+SD.
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Our results have implications for the identification of AMR in
clinical samples. In 5/38 (13.2%) of patient swabs, the most
prevalent AMR profile was not the most resistant (Figure 1).
Therefore, the number of isolates chosen for AMR testing can
greatly influence whether the full AMR profile present in the
patient’s sample is detected. Using mathematical modelling
and the data from our patient population, we demonstrate that
18 colonies must be tested to detect all the resistances with
95% confidence. Thus, if only a few colonies from an MRSA carrier
are tested, the presence of rare resistances can easily be missed.
In this study, 20 subcolonies were experimentally tested and our
mathematical analysis suggests there is a nearly 5% chance that
some resistances were missed. Therefore, rare resistances might
not have been sampled in our subisolate populations, leading to a
possible overestimate of the probability of detecting all resis-
tances in the specimen. Undersampling of colonies leads to
underestimation of the reservoirs and incidence of resistance
genes in MRSA populations.
Rare resistancesmay bemore reliably detected if a sweep of col-
onies is sampled or if the specimen is plated onto selective agar for
each antibiotic of interest. In the future, straight-from-sample
molecular diagnostics may potentially identify rare resistances. If
a patient is about to be prescribed a particular antibiotic, knowing
whether there is a population of colonizing MRSA that could rapidly
dominatemay be clinically important. This studydid not investigate
other types of microbiology specimens. Chronic or contaminated
samples where populations may have time to evolve may be
more likely to have greater diversity, such as those colonizing the
nose or cystic fibrosis lung,17 while samples from systemic acute
infections are predicted to show less diversity due to bacterial
population bottlenecks.40 Further studies are necessary.
MRSA epidemiological studies have suggested ‘clouds’ of diver-
sity in nasal samples, based on WGS and SNP variation in the core
genome.14–16 Here, we demonstrate that variation in AMR and
MGEs wasmore prevalent than SNPs in human nasal populations,
consistent with the piglet S. aureus colonization model.10
Epidemiological studies that rely on typing methods that include
AMR or MGE profiles should consider this variation when interpret-
ing data. WGS by next-generation sequencing methods that gen-
erate short reads and scaffold them onto reference genomesmay
not consider all the AMR and MGE data and may underestimate
diversity.37 However, sequencing technologies that generate
longer reads (e.g. Oxford Nanopore or PacBio) can potentially
make extraction and analysis of MGEs and their AMR genes sim-
pler. When used to construct epidemiological or phylogenetic
relationships, these methods should consider the high level of
MGE movement detected within patients. Overall, isolates with
differing AMR and MGE profiles may be more related than previ-
ously considered and outbreak investigations involving nasal
screening may have underestimated the prevalence of endogen-
ous infection.
Our data suggested greater diversity in MGE profiles over time
(2012 versus 2013), but AMR profiles did not show significant
diversity over time. Since our 2012 patients were known to be
negative for groin colonization and our 2013 patients’ groin colon-
ization was unknown, an alternative explanation is that patients
colonized in multiple body sites carry more diverse populations
in the nose. These findings require further investigation to swab
multiple body sites and identify if particular MGEs are associated
with these different colonizing sites.
A limitation of our study design is that we did not screen for
loss of mecA within patients and cannot discount SCCmec is
also unstable during colonization. A further limitation is that the
free bacteriophages isolated from nasal samples may have
been induced during the phage isolation process. If so, the phages
were easily induced.
In conclusion, this study strongly suggests that genetic vari-
ation within nasal colonization populations is common. This is
important because HGTcan lead to the emergence of new isolates
with enhanced resistance, adaptation to new hosts, immune eva-
sion and pathogenic potential. Genome instability, possibly due to
fitness costs and loss of MGEs, may also be common in MRSA
nasal populations during colonization. An important consequence
of extensive diversity within nasal populations is that sampling
too few colonies from a specimen can lead to errors in AMR detec-
tion or identification of outbreak reservoirs.
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